Status:
COMPLETED
Behavior Enhances Drug Reduction of Incontinence (BE-DRI)
Lead Sponsor:
Carelon Research
Collaborating Sponsors:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
Urinary Incontinence (UI)
Eligibility:
FEMALE
21+ years
Phase:
NA
Brief Summary
The primary aim of this study is to test if the addition of behavioral treatment to drug therapy for the treatment of urge incontinence will increase the number of patients who can discontinue drug th...
Eligibility Criteria
Inclusion
- Inclusion:
- Female
- Urge predominant incontinence
- Incontinent \> 3 mos
- Available for 8 mos of followup
- Exclusion:
- Pregnancy or \< 6 mos post-partum
- Hypersensitivity to drug (tolterodine)
- Systemic disease that affects bladder function (e.g., Parkinson's disease, Multiple Sclerosis, spinal cord injury)
- History of extensive behavior treatment
Exclusion
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2006
Estimated Enrollment :
307 Patients enrolled
Trial Details
Trial ID
NCT00090584
Start Date
August 1 2004
End Date
August 1 2006
Last Update
June 17 2013
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama
Birmingham, Alabama, United States, 35233
2
University of California
San Diego, California, United States, 92103
3
Loyola University Medical Center
Maywood, Illinois, United States, 60153
4
University of Maryland
Baltimore, Maryland, United States, 21201